About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Thursday, September 28th, 2017

The QualityStocks
Daily Stock List


Tintina Resources, Inc. (TINTF)

OTC Markets, Marketwired, MarketWatch, Stockhouse, 4-Traders, and StreetInsider reported on Tintina Resources, Inc. (TINTF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Tintina Resources, Inc. is a resource enterprise focused on the development and mining of its 100 percent owned flagship property, the Black Butte Copper Project (the BBCP) in central Montana. Black Butte Copper is one of the highest grade copper deposits undergoing development globally. Tintina Resources is headquartered in White Sulphur Springs, Montana. The Company’s shares trade on the OTC Markets Group’s OTCQB.

Tintina Resources announced that it received notification from the Montana Department of Environmental Quality (MT DEQ) that the Black Butte Copper Mine Operating Permit (MOP) is now considered to be Complete and Compliant in accordance with all State rules and regulations relating to the operating plan of its proposed underground copper mine in Meagher County, Montana. The permitting process now moves to the development of a complete Environmental Impact Study (EIS).

Last week, Tintina Resources announced that it received a draft operating permit from the Montana Department of Environmental Quality (MT DEQ) Hard Rock Mining Bureau. The draft permit formally concludes the Completeness & Compliance review. In addition, it signifies the start of the Environmental Impact Statement (EIS).

The MT DEQ is finalizing the selection of an independent third-party contractor to prepare a wide-ranging EIS that will include all procedural and substantive elements of the Montana Environmental Policy Act. The expectation is that the EIS will take about one year to complete.

The Black Butte Copper Project will be a significant contributor to the economy of Central Montana and the entire state. The direct payroll alone will be greater than $12 million annually.

Mr. John Shanahan, Chief Executive Officer of Tintina Resources, stated, “The support we continue to receive from businesses and rural communities in Montana has been outstanding. We remain 100 percent committed to bringing this extraordinary project to fruition while meeting our very clear commitment to environmental stewardship. Exhaustive technical studies to date show we can operate in an environmentally sounds way while protecting our environment. We can and will do this while providing important economic opportunities for Montana.”

The design of the proposed underground mine is to provide economic opportunity to Central Montana. This is while completely protecting the Smith River Watershed. A summary of the Mine Operating Permit Application is on Tintina Resources’ website in the transparency library along with a 3D animation of the planned project presenting what the site will look like during mining operations and after full site reclamation.

Tintina Resources, Inc. (TINTF), closed Thursday's trading session at $0.0728, down 10.67%, on 9,200 volume with 3 trades. The average volume for the last 60 days is 34,453 and the stock's 52-week low/high is $0.044/$0.1049.

True Nature Holding, Inc. (TNTY)

InvestorsHub, Real Pennies, MarketWatch, Marketwired, Stockhouse, and OTC Markets reported on True Nature Holding, Inc. (TNTY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

True Nature Holding, Inc.’s business plan considers a roll-up of businesses in the compounding pharmacy industry. The plan contemplates numerous acquisitions of businesses, which have conventionally operated locally, but that have specialty formulations that may have a larger market. The Company is targeting the acquisition of pharmacies that serve the human, and in some cases, pet markets. True Nature Holding is based in Atlanta, Georgia.

True Nature Holding has acquired 100 percent of the membership interests of Newco4pharmacy, LLC. Newco4pharmacy is a development stage business targeted at creating a network of compounding pharmacies.

The Company’s concentration is on the consolidation of the compound pharmacy industry. Its plan is to acquire a series of businesses that specialize in compounding pharmacy activities, principally direct to consumers, and to doctors and veterinary professionals. Pharmaceutical compounding is performed in compounding pharmacies. It is the creation of a specific pharmaceutical product to fit the exclusive need of a patient.

True Nature is creating a blend of human and veterinary businesses, and a balance of cash oriented operations, and more usual insurance based operations. It expects to create three operating subsidiaries to hold its planned acquisitions, while maintaining its current holding company structure for the publicly held entity. The expectation is that all the new subsidiaries will be wholly-owned, single member LLC's, controlled and managed by the public company.

True Nature Holding is launching a new initiative targeted at supporting the need for lower cost pharmaceuticals within the medically underserved small town and rural marketplaces. Its intention is to create a joint venture (JV) for-profit subsidiary; True Nature Community Health, Inc. This will be owned by the public company, and a newly formed not-for-profit entity; The True Nature Community Health Foundation.

True Nature Holding is in the process of acquiring the newly formed subsidiary, True Nature Community Health, Inc. (Community Health Subsidiary). It will have an 80 percent ownership in the Community Health Subsidiary. The remaining 20 percent ownership will be held by not-for-profit organizations with purposes of enhancing the availability of compounded drugs and other pharmaceuticals to medically underserved rural communities, or advancing social enterprise businesses that aim to address community health needs in similar areas.

True Nature Holding’s intention is to move ahead with its plans to enter the retail pharmacy space by way of "mini-stores" situated within smaller, second tier grocery sites. The Company believes that those sites centered on the Hispanic market represent excellent, underserved market opportunities. To determine the best strategy, True Nature is analyzing data from industry experts.

True Nature Holding, Inc. (TNTY), closed Thursday's trading session at $0.1445, up 23.50%, on 115,971 volume with 31 trades. The average volume for the last 60 days is 38,629 and the stock's 52-week low/high is $0.0418/$0.6799.

Strata Oil & Gas, Inc. (SOIGF)

AllPennyStocks and Investing Daily reported earlier on Strata Oil & Gas, Inc. (SOIGF) and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Strata Oil & Gas, Inc. is an enterprise leading the field in the exploration and development of bitumen from carbonates in the Province of Alberta. The Company concentrates on the exploration and development of heavy oil and bitumen. It has an interest in oil sands leases in the Peace River oil sands region of northern Alberta. Incorporated in 1998, Strata Oil & Gas is headquartered in Peace River, Alberta.

Strata Oil & Gas’ land base comprises approximately 60,672 hectares (over 149,000 acres) in the Peace River area. The estimation is that this region contains in excess of 188 billion barrels of oil. The Peace River oil sands area is one of the most productive oil-producing areas in Alberta.  

Strata’s Cadotte Central project is just north of Shell Canada's Carmon Creek project. It is adjoining Husky's property holdings in Peace River. Strata’s Cadotte West project is just north of Shell Canada's Carmon Creek project. It is adjacent to Koch Industries and Penn West property holdings in Peace River. 

In 2016, Strata Oil & Gas entered into an agreement to acquire the rights to greater than 20,000 acres of oil sands leases in the Peace River oil sands area. This increases the size of its Alberta oil sands holdings by a factor of around 50 percent. The rights extend from the Peace River formation to the base of the Pekisko formation. These lands are next to the Company’s Cadotte Project. They are within the same carbonate trend. 

Strata Oil & Gas entered into an agreement to acquire the rights to 115 sections (73,600 acres) of oil sands leases in the Peace River oil sands region. This increases the size of its Peace River Alberta oil sands holdings to greater than 230 sections. The lands are neighboring Baytex Energy Corp.'s Reno project lease block in the southern portion of the Peace River oil sands region. This is an area with extensive primary production. The new lease area is complementary to the Company’s existing Cadotte Project. 

Strata Oil & Gas announced this past February that it entered into a Letter of Intent (LOI) with Petrosteam LLC to obtain an exclusive license to deploy patented and field tested proprietary technologies utilizing steam generation applied to bitumen and heavy oil recovery (the Petrosteam Technology) in Alberta and Saskatchewan.

With this exclusive license, it has the exclusive right to use the Petrosteam Technology to produce within Alberta and Saskatchewan from its own properties and from those of others. 

The Petrosteam Technology has been field tested. Petrosteam is the exclusive owner of the patented Petrosteam Technology on an international basis.

Strata Oil & Gas believes that carbonate-hosted bitumen is one of the next major frontiers in the oil industry in the Province of Alberta. The Company has positioned itself to take advantage of this.

Strata Oil & Gas, Inc. (SOIGF), closed Thursday's trading session at $0.015, down 0.26%, on 12,169 volume with 2 trades. The average volume for the last 60 days is 20,540 and the stock's 52-week low/high is $0.01/$0.08.

ForeverGreen Worldwide Corporation (FVRG)

MarketWatch, OTC Markets, InvestorsHub, 4-Traders, and MicroCapDaily reported on ForeverGreen Worldwide Corporation (FVRG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTC Markets’ OTCQB, ForeverGreen Worldwide Corporation is a global direct marketing enterprise and provider of health and wellness products. The Company develops, manufactures, and distributes a wide-ranging line of all-natural whole foods and products to North America, Australia, Europe, Asia, and South America. ForeverGreen Worldwide has its corporate headquarters in Lindon, Utah. The Company was formed in May of 2004 by Chief Executive Officer and Chairman Mr. Ron Williams.

ForeverGreen Worldwide’s products include its new global Xpress offering Prodigy-5™, featuring the exclusive TransArmor™ Nutrient Technology. Products also include PowerStrips™, SolarStrips™, with industry exclusive marine phytoplankton and BeautyStrips™.

Additionally, the Company offers the North American market its weight-management line called Ketopia™, and also additional weight management products. It also offers its Pulse-8™ powered L-arginine formula for cardiovascular health.

Earlier this month, ForeverGreen™ Worldwide reported 5 percent revenue growth in August over July. Moreover, it has experienced record growth within the last 90 days as an extension of its European business in Réunion Island, Greece, as well as Cyprus.

ForeverGreen™ Worldwide recently announced its new wearable technology named CareWear™. The presale of this device, with continuous monitoring from the health application GoHeart, is a limited time offer with a first-time association of use with the Company's nutrition products.

CareWear, in combination with daily use of ForeverGreen nutritional products, is what ForeverGreen Worldwide is positioning as the Total Health Experience, which completes the outside edge of nature, science, products, education and technology formulated in research and development (R&D) of all ForeverGreen’s product offerings.

ForeverGreen Worldwide Chief Executive Officer, Mr. Rick Redford, said, ""ForeverGreen is in a unique position where the CareWear device becomes the catalyst for people to monitor and manage their lives with a health dashboard, and see the results from use of ForeverGreen nutrition products. Global sales for the wearable technology market is expected to exceed $34 billion in 2020, according to CCS Insight. The strength of our message is that the device is a piece of a much bigger strategy we are calling the, 'Total Health Experience.'"

ForeverGreen Worldwide Corporation (FVRG), closed Thursday's trading session at $0.14, down 2.78%, on 36,698 volume with 12 trades. The average volume for the last 60 days is 8,512 and the stock's 52-week low/high is $0.14/$0.40.

Applied Minerals, Inc. (AMNL)

Real Pennies and Wall Street Resources reported earlier on Applied Minerals, Inc. (AMNL), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Applied Minerals, Inc., via its ownership of the historic Dragon Mine deposit, is the leading global producer of Dragonite™ halloysite clay and Amiron™ advanced natural iron oxides. The Company’s products address the worldwide need for high performance, eco-friendly solutions for an assortment of industrial applications. Applied Minerals is headquartered in New York, New York.

In 2014, Applied Minerals launched its AMIRON line of advanced natural iron oxide pigments to the construction, wood coatings, paints, industrial coatings, plastics and rubber markets. Halloysite is an aluminosilicate clay. It exhibits a rare, naturally occurring hollow tubular structure. Halloysite tubes have a length in the range of 0.5 - 3.0 microns, an exterior diameter in the range of 50 - 70 nanometers, and an internal diameter (lumen) in the range of 15 - 30 nanometers.

The Company’s Dragonite™ is a versatile Halloysite product grade. It has a wide array of applications. It is an advanced reinforcing filler.

The Company serves the traditional halloysite markets for use in technical ceramics and catalytic applications. Applied Minerals is the foremost producer of Halloysite clay and advanced, ultra-pure natural iron oxide solutions –comprising hematite and goethite - from its wholly-owned Dragon Mine property in Utah.

Furthermore, the Company has developed niche applications, which benefit from the tubular morphology of its halloysite. These applications include carriers of active ingredients in paints, coatings and building materials, environmental remediation, agricultural applications, and high-performance additives & fillers for plastic composites.

The Company’s Dragonite-XR™ product grade provides unique advantages in comparison to other reinforcing fillers, including glass fiber, mica, wollastonite or talc.

Applied Minerals’ Dragonite-HP™ is a high-performance additive for engineering thermoplastics used at loadings of only 1-3 percent. It provides premier mechanical performance and cycle time reduction. In addition, its Dragonite-PureWhite™ is the highest purity Dragonite™ product. It meets the strict specifications of the cosmetic industry.

Regarding Iron Oxide products, Applied Minerals offers the aforementioned Amiron. This is an advanced natural iron oxide for a variety of pigmentary and technical applications.

Recently, Applied Minerals announced that it entered into agreements to amend the terms of its Series A Convertible PIK Notes and Series 2023 Convertible PIK Notes, in association with a financing of $0.9 million led by Fimatec, Ltd., one of Japan's top specialty minerals producers and a strategic distribution partner of Applied Minerals focused on sales of DRAGONITE products to the Japanese market.

Applied Minerals believes the amendments to the notes will provide the Company the proper capital structure, which will enable it to remain centered on supporting its present customers and converting its increasing pipeline of revenue opportunities for its DRAGONITE™ halloysite clay and AMIRON™ natural iron oxide products.

Applied Minerals, Inc. (AMNL), closed Thursday's trading session at $0.04, even for the day. The average volume for the last 60 days is 26,112 and the stock's 52-week low/high is $0.015/$0.16.


The QualityStocks
Company Corner


92 Resources Corp. (TSX.V: NTY) (OTCQB: RGDCF) (FSE: R9G2)

The QualityStocks Daily Newsletter would like to spotlight 92 Resources Corp. (RGDCF). Today, 92 Resources Corp. closed trading at $0.095, up 14.05%, on 29,600 volume with 4 trades. The stock’s average daily volume over the past 60 days is 17,616 and its 52-week low/high is $0.071/$0.1318.

NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring 92 Resources Corp. (TSX VENTURE: NTY) (OTCQB: RGDCF) (FRANKFURT: R9G2), a client of NNW and a modern energy solutions company focused on acquiring and advancing strategic and prospective energy-related projects in Canada. The publication, titled, "Lithium, Fuelling the New Millennium," discusses the companies trying to meet the growing demand for lithium and how market supply and price are impacting key industry players. To view the full publication, visit: https://www.networknewswire.com/lithium-fuelling-new-millennium/

92 Resources Corp. (TSX.V: NTY) (OTCQB: RGDCF) is a modern energy solutions company focused on acquiring and advancing strategic and prospective energy-related projects in Canada. Its three principal assets include the Hidden Lake Lithium Property in the Northwest Territories, the Pontax Lithium Property in Quebec, and the Golden Frac Sand Property in British Columbia.

Preliminary mineralogy work on samples taken of the Hidden Lake pegmatites indicate spodumene – the world's richest source of lithium – is of a high quality and near the maximum theoretical limit. Scoping testwork saw an overall lithium extraction of 97 percent from the concentrate produced from these pegmatites, which means standard lithium extraction techniques can be applied, making the extraction of lithium easier and more cost effective.

92 Resources is focused on developing the lithium-rich resources located within its properties through open-pit mining and relatively straight-forward mineral processing procedures. Surface exploration programs that include prospecting, mapping and sampling of known spodumene-bearing pegmatites on the Hidden Lake property suggests the existence of one massive, interconnected body of pegmatite below the surface. Recent acquisitions of prospective hard-rock lithium properties in Quebec add to the company's impressive and growing asset portfolio.

Recent acquisitions of prospective hard-rock lithium properties in Quebec add to the company's impressive and growing asset portfolio. The properties, known as Corvette, Eastmain and Lac Du Beryl, consist of a combined 115 mineral claims totaling approximately 14,710 acres with confirmed pegmatite outcrops visible at each location. Some sampling has been completed at the Corvette property and shows spodumene crystals present, making this location a high priority for follow up work. Analytical results are pending on samples taken from known pegmatite outcrops visible at each property.

Lithium is a strategic, green metal used in batteries, electronics, electric vehicles, ceramics, alloys, lubricants and pharmaceuticals. The world market for electric vehicles, with China as its biggest customer, is exponentially growing as the demand for clean, renewable energy sources increases. A recent report by Grand View Research, Inc. places the lithium-ion battery market worldwide at $93 billion by 2025, with a compound annual growth rate of 17%.

92 Resources is led by an experienced management team and advisors with decades of expertise in market strategies, corporate development, mineral exploration and energy development. With an excellent team of professionals and promising mining projects, the company is well positioned to capitalize on the ever-rising demand for lithium. Disclaimer

92 Resources Corp. Blog

92 Resources Corp. News:

NetworkNewsWire Announces Publication Discussing the Impact of Lithium Demand on Several Public Companies

Lithium, Fuelling the New Millennium

92 Resources Corp. Acquires Three New Properties in Quebec

InMed Pharmaceuticals, Inc. (CSE:IN) (OTCQB:IMLFF)

The QualityStocks Daily Newsletter would like to spotlight InMed Pharmaceuticals, Inc. (IMLFF). Today, InMed Pharmaceuticals, Inc. closed trading at $0.40, even for the day, on 991,483 volume with 340 trades. The stock’s average daily volume over the past 60 days is 416,090, and its 52-week low/high is $0.08/$0.72.

NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF), a client of NNW specializing in the development of novel therapeutics leveraging the pharmacological benefits of cannabinoids. The publication, titled, "Medical Cannabis Companies Leverage Biosynthesis to Boost Drug Development," discusses companies bringing cannabis-based solutions to the medical marijuana market. To view the full publication, visit: https://www.networknewswire.com/medical-cannabis-companies-leverage-biosynthesis-boost-drug-development/

InMed Pharmaceuticals, Inc. (IMLFF) is a preclinical-stage biopharmaceutical company specializing in the development of novel therapeutics leveraging the pharmacological benefits of cannabinoids. Utilizing its proprietary bioinformatics assessment tool, InMed aims to identify bioactive compounds found within the cannabis plant that have the potential to offer optimized therapeutic benefit while demonstrating limited adverse effects. This assessment tool, in combination with the company’s cannabinoid biosynthesis technology and drug development pipeline, serves as InMed’s fundamental value driver.

Bioinformatics is a proprietary, computer-based program designed to assist in the identification of novel cannabinoids using comprehensive algorithms to integrate data from numerous bioinformatics databases, as well as a database on the structure of currently approved pharmaceutical products and an extensive database on over 90 individual cannabinoid drugs found in cannabis. This extensive collection of data is derived from both public and propriety-based sources. Leveraging this tool, the company aims to create associations between approved pharmaceuticals and cannabinoids with similar structures in order to identify active cannabinoids that have the potential to treat specific diseases. Per InMed’s website, this type of bioinformatics assessment represents “significant promise for future drug discovery, as it integrates many data sets and builds holistic models to approach a specific disease.”

After discovering these promising active cannabinoids, InMed moves to test and confirm their activity in biological systems through in vitro and in vivo experimentation. It is at this stage of development that the company’s proprietary biosynthesis process of cannabinoid manufacturing will be most promising. InMed is currently developing a robust, high-yield biosynthesis process for manufacturing all 90+ naturally-occurring cannabinoids. By modifying the agriculture-based formula for harvesting cannabinoids, InMed aims to combine the inherent safety and known efficacy of the natural drug structure with the convenience, control and quality of 21st Century laboratory-based manufacturing processes.

The company’s pipeline currently includes two drug candidates in preclinical development, including INM-750 for the treatment of epidermolysis bullosa (EB) and INM-085 for the treatment of glaucoma. Referred to by the Dystrophic Epidermolysis Bullosa Research Association of America as “The Worst Disease You’ve Never Heard Of,” EB is a rare genetic connective tissue disorder that affects roughly one out of every 20,000 births in the United States. The condition currently has no approved treatment or cure. Through the development of INM-750, InMed is attempting to address this significant unmet medical need. The drug candidate replaces missing keratins in the skin with specially selected cannabinoids in an effort to modulate the painful manifestations of EB.

INM-085, InMed’s second development candidate, is formulated to reduce the elevated intra-ocular pressure that is often associated with glaucoma. Additionally, the cannabinoids utilized in INM-085 are expected to provide neuroprotection for the retinal ganglion cells and other optic nerve tissues following topical administration. Although it is still in preclinical development, INM-085 targets a sizable market. According to the Glaucoma Research Foundation, glaucoma is a leading cause of blindness with no approved cure. The National Institutes of Health estimates that more than 3 million Americans currently have glaucoma, and more than 120,000 have been blinded by the disease.

InMed is focused on progressing toward validation of its drug candidate selection, using data to secure its patents and developing key disruptive technologies. In 2016, the company was successful in completing financings of $1.9 million. In January 2017, InMed completed a non-brokered private placement of common shares generating aggregate gross proceeds of C$1.5 million, strongly positioning the company to attract the new investment required to fund its aggressive growth strategies in 2017.

The company’s management team has well over a century of combined experience in the biopharmaceutical space. Company CEO Eric Adams has more than 25 years of experience in company and capital formation, global market development, mergers and acquisitions, licensing and corporate governance. During his time as CEO of enGene Inc., he led the gene therapy startup to a position at the head of the industry.

Joining Adams on the InMed management team are Chief Scientific Officer Dr. Sazzan Hossain; Senior Vice President, Clinical and Regulatory Affairs Alexandra D.J. Mancini; SVP, Corporate Strategy & Investor Relations Chris Bogart; and Chief Financial Officer Jeff Charpentier, as well as Chief Medical Officer Dr. Ado Muhammed, MD, DPM, MFPM.

Muhammed, in particular, has an extensive history in the pharmaceutical industry, having previously served as an executive of GW Pharmaceuticals, a global leader in the development of cannabinoid-based medicines. During his time as Associate Medical Director of that company, Muhammed played an instrumental role in the development and FDA approval of one of the first cannabis drugs. This GW Pharmaceuticals development program coincided with a sharp rise in share price from less than $9 in 2013 to more than $129 today, with the company’s current market value totaling more than $2.9 billion. Disclaimer

InMed Pharmaceuticals, Inc. Company Blog

InMed Pharmaceuticals, Inc. News:

NetworkNewsWire Announces Publication Highlighting Unique Technology in Cannabinoid-Based Medicine

NetworkNewsWire Announces Publication on Advances in Cannabinoid-Based Medicine

InMed Continues to Make Significant Strides on Biosynthesis Program Development

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE). Today, Global Payout, Inc. closed trading at $0.0185, up 1.37%, on 1,687,795 volume with 64 trades. The stock’s average daily volume over the past 60 days is 2,433,400, and its 52-week low/high is $0.0077/$0.04.

NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Global Payout, Inc. (OTC Pink: GOHE), a client of NNW that provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The publication, titled, "Standout Players in the FinTech Revolution Contribute to the Shakeup of Traditional Banking," shines a light on companies shaking up traditional banking with FinTech solutions. To view the full publication, visit: https://www.networknewswire.com/standout-players-fintech-revolution-contribute-shakeup-traditional-banking/

Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout's fully configurable "banking-in-a-box" web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today's banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout's management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and "high-risk" market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and "high-risk" enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions. Disclaimer

Global Payout, Inc. Company Blog

Global Payout, Inc. News:

NetworkNewsWire Announces Publication Discussing FinTech's Role in Disrupting Traditional Financial Services

MoneyTrac Techology, Inc. Announces Revenue Through Completion of Acquisition of Southern California-Based Periodical Brand, PotSaver

NetworkNewsWire Announces Publication on the Widespread Impact of FinTech

AppSwarm, Inc. (SWRM)

The QualityStocks Daily Newsletter would like to spotlight AppSwarm, Inc. (SWRM). Today, AppSwarm, Inc. closed trading at $0.012, up 8.11%, on 158,274 volume with 8 trades. The stock’s average daily volume over the past 60 days is 179,666 and its 52-week low/high is $0.002/$0.075.

AppSwarm, Inc. (SWRM) is a technology development and incubation acceleration company that partners up with developers through joint ventures, royalty agreements, marketing partnerships, and outright purchase agreements. Focusing on the ever-growing mobile applications market, the company provides all the resources needed for engagement, retention, virality and monetization.

The global games market generated approximately $100 billion in revenues in 2016, but large global game companies have made it extremely difficult for smaller developers to achieve success in the marketplace. As a result, many great ideas aren't monetized. AppSwarm solves this problem by providing the funding and critical business expertise needed to successfully launch and market new applications.

Business applications is another area of focus for the company. Targeting small to medium sized businesses, AppSwarm will be developing and acquiring mobile application tools and platforms that increase productivity and security via data encryption, cloud storage, content management and delivery, digital payments, automation, and customer loyalty marketing solutions. Recent acquisitions made so far represent only a small example of future planned initiatives to develop and market tools for the business community.

Regardless of the target market, AppSwarm can help developers accelerate the success of their app through funding, technology and marketing expertise, as well as a unique eco system that accelerates user acquisition. The company is able to assist at any state of development with completion of concept, market analysis, business and financial management, direct sales and marketing, social game development to ensure correct product application and expedient deployment with cost efficiency.

Ron Brewer, CEO of the company, has accumulated extensive leadership in the technology sector and brings valuable knowledge gained as a Director of Southbridge Advisory Group for nearly 20 years. Ron's C-level experience includes merger & acquisition and post-acquisition turnaround in both the private and small-cap public sector. John Rabbit, director of finance, is a seasoned business veteran that has worked with Fortune 500 firms and served in CEO, COO and CFO positions for firms ranking from $5 million to $300 million in annual revenues. John was directly involved in numerous acquisitions and served in executive capacities for several multinational subsidiaries.

With a well-suited management team, multiple synergistic revenue streams, and diversified growth strategy, AppSwarm is well positioned in a steadily growing industry with countless opportunities for capitalization. Disclaimer

AppSwarm, Inc. Blog

AppSwarm, Inc. News:

AppSwarm, Inc. is Developing Last-Mile Delivery Application Management Platform

NetworkNewsWire Releases Exclusive Audio Interview with AppSwarm, Inc. (SWRM)

AppSwarm, Inc. (SWRM) Engages NetworkNewsWire for Corporate Communications Solutions

ORHub, Inc. (ORHB)

The QualityStocks Daily Newsletter would like to spotlight ORHub, Inc. (ORHB). Today, ORHub, Inc. closed trading at $0.61, up 8.93%, on 52,816 volume with 24 trades. The stock’s average daily volume over the past 60 days is 65,907 and its 52-week low/high is $0.20/$2.09.

ORHub, Inc. (ORHB) is a cloud-based software platform designed to transform the business of surgery into a value-based model. The platform empowers care providers at every stage of the surgical process to collaborate, organize, deliver, measure, and reimburse in one intuitive, easy-to-use program. This significantly decreases cost and improves outcomes by eliminating inefficiencies, duplications of effort, and errors and omissions that result from siloed processes in outdated software and poor handoffs from one part of the care process to another.

The need for ORHub is clear. Health care costs are out of control at more than 17% of US GDP, which equates to over $3 trillion per year. With costs rising every year due to an aging population and increasingly expensive treatments, providers are under severe pressure to become more efficient and reduce costs. This is happening because payors are aggressively reducing reimbursements and finally moving away from fee-for-service and toward a performance-based reimbursement system referred to as value-based health care.

Accurately measuring the cost of treating a condition and relating that cost to the patient's outcome is at the heart of value-based health care. Institutions that have adopted this model have reaped savings of 20-40% on their overall cost of care. Unfortunately, today's siloed IT systems are fundamentally at odds with this process. Legacy health care solutions come from a fee-for-service world and have reinforced the problem and produced a system with erratic quality and unsustainable costs. Most health care applications today are incremental improvements on these existing systems or are simple digital implementations of antiquated pen-and-paper processes.

Providers wanting to practice value-based health care need value-based software. ORHub creates a value-based solution that will revolutionize surgical care delivery by tracking the cost of treating a condition from diagnosis to discharge, and tracking outcomes that resulted from that treatment.

In an industry where major IT rollouts traditionally cost millions of dollars and take an average of eighteen months, pilot installations of ORHub have been completed in less than a month. By avoiding integration with legacy systems completely through a radically comprehensive and collaborative approach, providers see results right away. This approach produces real-time metrics in a uniform manner at any institution, which makes it ideal for large providers looking to make improvements across the board at multiple facilities.

ORHub started as a pilot program developed in cooperation with a major Southern California hospital. It has since expanded operations into a second facility at the number two non-profit hospital system in the US. Three additional pilot programs are scheduled prior to a national launch. The company has raised more than $1.6 million as of January 2017.

The company is also a showcase member of the startup program at Microsoft, which has been a key partner by providing financial assistance, strategy, introductions to influencers and mentors, and access to its sales organization who see ORHub as an exciting partner to expand the utilization of Microsoft Surface devices and Azure Cloud. Microsoft is funding a major case study in partnership with Intel about the impact of ORHub on participating institutions to be concluded sometime in Q2 2017.

ORHub's leadership team is helmed by Colt Melby, who was appointed CEO in 2016 and has been crucial to developing and executing the company's business strategy. Mr. Melby's extensive business experience includes the NASDAQ uplisting of Smith and Wesson (now American Outdoor Brands), CUI Global Inc., and Quest Resource Holdings Corp. His wealth of information and relationships have been vital in helping the company go from concept to production in institutional medicine in less than a year.

Delivering surgical care to a single patient is a complex process that may take half a dozen companies and more than a dozen departments cooperating inside and outside the care facility. ORHub simplifies and streamlines this process by enabling vendors, providers, and surgeons to collaborate on providing care. Disclaimer

ORHub, Inc. Blog

ORHub, Inc. News:

ORHub, Inc. Completing 2-Year Financial Audit for Advancement to the OTCQB Market

ORHub (ORHB) Announces COO Leave of Absence

ORHub (ORHB) Joins ICHOM TechHub to Propel Value-Driven Improvements in Healthcare


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



(AMMA) +87.50%


Jason Bond
(OMNT) +66.29%


(ZYNE) +52.50%

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251